Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniela Merlotti

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Nutrients|November 25, 2023
The Effect of Vitamin D on Metabolic Bone Disease and Chronic DiseasesSalvatore Minisola, Daniela Merlotti
Advances in Clinical Chemistry|August 31, 2011
Aromatase activity and bone lossLuigi Gennari, Daniela Merlotti, Ranuccio Nuti
Clinical Interventions in Aging|February 20, 2010
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifeneLuigi Gennari, Daniela Merlotti, Ranuccio Nuti
Journal of Osteoporosis|July 21, 2011
Aromatase activity and bone loss in menDaniela Merlotti, Luigi Gennari, Konstantinos Stolakis, et al.
International Journal of Endocrinology|June 2, 2018
The Potential Role of miRNAs as New Biomarkers for OsteoporosisMaria Materozzi, Daniela Merlotti, Luigi Gennari, et al.
Expert Opinion on Pharmacotherapy|February 1, 2020
Treatment options for glucocorticoid-induced osteoporosisIacopo Chiodini, Daniela Merlotti, Alberto Falchetti, et al.
Expert Opinion on Investigational Drugs|August 19, 2006
Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosisLuigi Gennari, Daniela Merlotti, Giuseppe Martini, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 24, 2012
Pharmacokinetic evaluation of toremifene and its clinical implications for the treatment of osteoporosisLuigi Gennari, Daniela Merlotti, Konstantinos Stolakis, et al.
Expert Opinion on Drug Discovery|June 1, 2012
Lasofoxifene, from the preclinical drug discovery to the treatment of postmenopausal osteoporosisLuigi Gennari, Daniela Merlotti, Konstantinos Stolakis, et al.
Open Access Rheumatology : Research and Reviews|July 17, 2009
Current options for the treatment of Paget's disease of the boneDaniela Merlotti, Luigi Gennari, Giuseppe Martini, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Nutrients|November 25, 2023
The Effect of Vitamin D on Metabolic Bone Disease and Chronic DiseasesSalvatore Minisola, Daniela Merlotti
Advances in Clinical Chemistry|August 31, 2011
Aromatase activity and bone lossLuigi Gennari, Daniela Merlotti, Ranuccio Nuti
Clinical Interventions in Aging|February 20, 2010
Selective estrogen receptor modulator (SERM) for the treatment of osteoporosis in postmenopausal women: focus on lasofoxifeneLuigi Gennari, Daniela Merlotti, Ranuccio Nuti
Journal of Osteoporosis|July 21, 2011
Aromatase activity and bone loss in menDaniela Merlotti, Luigi Gennari, Konstantinos Stolakis, et al.
International Journal of Endocrinology|June 2, 2018
The Potential Role of miRNAs as New Biomarkers for OsteoporosisMaria Materozzi, Daniela Merlotti, Luigi Gennari, et al.
Expert Opinion on Pharmacotherapy|February 1, 2020
Treatment options for glucocorticoid-induced osteoporosisIacopo Chiodini, Daniela Merlotti, Alberto Falchetti, et al.
Expert Opinion on Investigational Drugs|August 19, 2006
Lasofoxifene: a third-generation selective estrogen receptor modulator for the prevention and treatment of osteoporosisLuigi Gennari, Daniela Merlotti, Giuseppe Martini, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 24, 2012
Pharmacokinetic evaluation of toremifene and its clinical implications for the treatment of osteoporosisLuigi Gennari, Daniela Merlotti, Konstantinos Stolakis, et al.
Expert Opinion on Drug Discovery|June 1, 2012
Lasofoxifene, from the preclinical drug discovery to the treatment of postmenopausal osteoporosisLuigi Gennari, Daniela Merlotti, Konstantinos Stolakis, et al.
Open Access Rheumatology : Research and Reviews|July 17, 2009
Current options for the treatment of Paget's disease of the boneDaniela Merlotti, Luigi Gennari, Giuseppe Martini, et al.
Pageof 8